The DOI matches its Crossref record; 301 of the 301 references it cites were found in a registry or an index.
Nucleus accumbens shell and core dopamine: differential role in behavior and addiction
Abstract
Drug addiction can be conceptualized as a disturbance of behavior motivated by drug-conditioned incentives. This abnormality has been explained by Incentive-Sensitization and Allostatic-Counteradaptive theories as the result of non-associative mechanisms acting at the stage of the expression of incentive motivation and responding for drug reinforcement. Each one of these theories, however, does not account per se for two basic properties of the motivational disturbance of drug addiction: (1). focussing on drug- at the expenses of non-drug-incentives; (2). virtual irreversibility. To account for the above aspects we have proposed an associative learning hypothesis. According to this hypothesis the basic disturbance of drug addiction takes place at the stage of acquisition of motivation and in particular of Pavlovian incentive learning. Drugs share with non-drug rewards the property of stimulating dopamine (DA) transmission in the nucleus accumbens shell but this effect does not undergo habituation upon repeated drug exposure, as instead is the case of non-drug rewards. Repetitive, non-decremental stimulation of DA transmission by drugs in the nucleus accumbens septi (NAc) shell abnormally strengthens stimulus-drug associations. Thus, stimuli contingent upon drug reward acquire powerful incentive properties after a relatively limited number of predictive associations with the drug and become particularly resistant to extinction. Non-contingent occurrence of drug-conditioned incentive cues or contexts strongly facilitates and eventually reinstates drug self-administration. Repeated drug exposure also induces a process of sensitization of drug-induced stimulation of DA transmission in the NAc core. The precise significance of this adaptive change for the mechanism of drug addiction is unclear given the complexity and uncertainties surrounding the role of NAc core DA in responding but might be more directly related to instrumental performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This neural system comprises subcortical and cortical structures that are major sites of dopamine action, and include primarily the striatum (caudate nucleus, putamen and nucleus accumbens) (e.g., Di Chiara, 2002; Di Chiara and Bassareo, 2007; McClure et al., 2004; Schultz et al., 1998; Wise, 2004) and the medial and orbital prefrontal cortices (Jensen et al., 2003; Kringelbach, 2005).”
From A systematic review of fMRI reward paradigms used in studies of adolescents vs. adults: The impact of task design and implications for understanding neurodevelopment (2013) · cites this paper as Di Chiara, 2002
In the citing paper
“The primary subcortical brain target is the nucleus accumbens (NAc) which is considered the center of the reward circuitry and heavily implicated in substance use and craving [18–22].”
In the citing paper
“To date, much of the functional analysis of the nucleus accumbens has focused on the differences between the accumbens core and shell, and many studies found that the core and shell are involved in different functions (Di Chiara, 2002; Kelley, 2004; Everitt and Robbins, 2005).”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Di Chiara, 2002
In the citing paper
“Since our review (Ikemoto and Panksepp, 1999), many studies have been conducted providing rich data indicating differential functions between the medial portion of the nucleus accumbens shell and the core in appetitive tasks (see Di Chiara, 2002; Kelley, 2004; Everitt and Robbins, 2005).”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Di Chiara, 2002
In the citing paper
“Indeed, behavioral data indicate otherwise (Di Chiara, 2002; Kelley, 2004; Everitt and Robbins, 2005, Yin and Knowlton, 2006).”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Di Chiara, 2002
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Psychology as the behaviorist views it
Watson, J. B. (1913) · Psychological Review · doi:10.1037/h0074428 · Cited by 3,230
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Kalivas, P., & Stewart, J. (1991) · Brain research. Brain research reviews · doi:10.1016/0165-0173(91)90007-u · Cited by 2,087
Research works printed but not linked: 1
- Himmelsbach, 1943, Morphine, with reference to physical dependence, Fed. Proc., 2, 201
Cited by
Sorted by citations
Items 301–400 of 999
Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
Yuen, J., Kouzani, A. Z., Berk, M., Tye, S. J., Rusheen, A. E., Blaha, C. D., Bennet, K. E., Lee, K. H., Shin, H., Kim, J. H., et al. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01229-4 · Cited by 54
Bassareo, V., Musio, P., & Chiara, G. D. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2072-8 · Cited by 52
Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens
Rada, P. V., Barson, J. R., LEIBOWITZ, S. F., & Hoebel, B. G. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.055 · Cited by 50
Lloyd, K., & Dayan, P. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004622 · Cited by 51
Leggio, G. M., Cathala, A., Moison, D., Cunningham, K. A., Piazza, P. V., & Spampinato, U. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.10.005 · Cited by 50
Cadoni, C., & Chiara, G. D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04795.x · Cited by 49
Fenu, S., Wardas, J., & Morelli, M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833109a0 · Cited by 49
MeCP2 Phosphorylation Limits Psychostimulant-Induced Behavioral and Neuronal Plasticity
Deng, J. V., Wan, Y., Wang, X., Cohen, S., Wetsel, W. C., Greenberg, M. E., Kenny, P. J., Calakos, N., & West, A. E. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2821-13.2014 · Cited by 50
Comparative gene expression in brain regions of human alcoholics
Flatscher‐Bader, T., Brug, M. P. V. D., Landis, N., Hwang, J. W., Harrison, E. M., & Wilce, P. A. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00197.x · Cited by 49
Antkiewicz‐Michaluk, L., Wąsik, A., & Michaluk, J. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9402-7 · Cited by 49
Solis, E., Cameron-Burr, K. T., Shaham, Y., & Kiyatkin, E. A. (2017) · eNeuro · doi:10.1523/eneuro.0151-17.2017 · Cited by 50
MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens
Sim, M. S., Soga, T., Pandy, V., Wu, Y. S., Parhar, I. S., & Mohamed, Z. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0061-x · Cited by 49
Blum, K., Chen, T. J. H., Meshkin, B., Waite, R. L., Downs, B. W., Blum, S. H., Mengucci, J. F., Arcuri, V., Braverman, E. R., & Palomo, T. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.12.062 · Cited by 49
Quarta, D., Leslie, C. P., Carletti, R., Valerio, E., & Caberlotto, L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.016 · Cited by 48
Maldonado, C., Rodríguez‐Arias, M., Castillo, A., Aguilar, M. A., & Miñarro, J. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000190685.84984.ec · Cited by 49
Bissonette, G. B., Gentry, R. N., Padmala, S., Pessoa, L., & Roesch, M. R. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00024 · Cited by 49
Panagis, G., Vlachou, S., & Nomikos, G. G. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801030350 · Cited by 48
Considerations in Addressing the Opioid Epidemic and Chronic Pain within the USA
Marshall, B., Bland, M. K., Hulla, R., & Gatchel, R. J. (2019) · Pain Management · doi:10.2217/pmt-2018-0070 · Cited by 48
Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review
Nardo, T., Batchelor, J., Berry, J., Francis, H., Jafar, D., & Borchard, T. (2021) · Neuropsychology Review · doi:10.1007/s11065-021-09506-3 · Cited by 48
Corda, M. G., Piras, G., Lecca, D., Fernández‐Teruel, A., Driscoll, P., & Giorgi, O. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.06.016 · Cited by 48
Siessmeier, T., Kienast, T., Wrase, J., Larsen, J. L., Braus, D. F., Smolka, M. N., Buchholz, H. G., Schreckenberger, M., Rösch, F., Cumming, P., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04903.x · Cited by 48
Brain Reward Systems for Food Incentives and Hedonics in Normal Appetite and Eating Disorders
Berridge, K. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012370633-1/50008-6 · Cited by 48
A molecularly defined D1 medium spiny neuron subtype negatively regulates cocaine addiction
Zhao, Z., Han, X., Chen, R., Liu, Y., Bhattacherjee, A., Chen, W., & Zhang, Y. (2022) · Science Advances · doi:10.1126/sciadv.abn3552 · Cited by 44
Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system
Hearing, M. C., Zink, A. N., & Wickman, K. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0045 · Cited by 50
Lepelletier, F.-X., Tauber, C., Nicolas, C., Solinas, M., Castelnau, P., Belzung, C., Emond, P., Cortese, S., Faraone, S. V., Chalon, S., et al. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu044 · Cited by 48
Hammad, A. M., Alasmari, F. F., Althobaiti, Y. S., & Sari, Y. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.017 · Cited by 48
Zhou, L.-F., & Zhu, Y.-P. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0107 · Cited by 47
Ihalainen, J. A., & Tanila, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02691.x · Cited by 47
Becker‐Krail, D. D., Walker, W. H., & Nelson, R. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.886704 · Cited by 48
Leggio, L., Ferrulli, A., Cardone, S., Miceli, A., Kenna, G. A., Gasbarrini, A., Swift, R. M., & Addolorato, G. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.03.128 · Cited by 46
The neurocircuitry involved in oxytocin modulation of methamphetamine addiction
Baracz, S. J., & Cornish, J. L. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.08.001 · Cited by 46
Loss of Cocaine Locomotor Response in Pitx3-Deficient Mice Lacking a Nigrostriatal Pathway
Beeler, J. A., Cao, Z. F. H., Kheirbek, M. A., & Zhuang, X. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.117 · Cited by 45
Peoples, L. L., & Cavanaugh, D. J. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00849.2002 · Cited by 45
Too Difficult to Stop: Mechanisms Facilitating Relapse in Alcohol Dependence
Garbusow, M., Sebold, M., Beck, A., & Heinz, A. (2014) · Neuropsychobiology · doi:10.1159/000362838 · Cited by 47
Achat‐Mendes, C., Anderson, K. L., & Itzhak, Y. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301119 · Cited by 45
Solis, E., Cameron-Burr, K. T., Shaham, Y., & Kiyatkin, E. A. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.181 · Cited by 47
Jerabek, P., Havlickova, T., Puskina, N., Charalambous, C., Lapka, M., Kačer, P., & Šustková-Fišerová, M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.09.013 · Cited by 45
Papathanou, M., Dumas, S., Pettersson, H. I., Olson, L., & Wallén‐Mackenzie, Å. (2019) · eNeuro · doi:10.1523/eneuro.0198-19.2019 · Cited by 45
Addiction: the clinical interface
Nutt, D., & Lingford-Hughes, A. R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.101 · Cited by 46
Programming effects of antenatal dexamethasone in the developing mesolimbic pathways
Leão, P., Sousa, J. C., de Oliveira, M. A. R., Silva, R., Almeida, O. F. X., & Sousa, N. (2006) · Synapse · doi:10.1002/syn.20341 · Cited by 45
Beaudry, G., Zekki, H., Rouillard, C., & Lévesque, D. (2003) · Synapse · doi:10.1002/syn.10302 · Cited by 45
Segovia, K. N., Correa, M., & Salamone, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.078 · Cited by 44
The Role of CaMKII and ERK Signaling in Addiction
Jia, W., Kawahata, K., Cheng, A., & Fukunaga, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063189 · Cited by 44
Symptoms, Mechanisms, and Treatments of Video Game Addiction
Mohammad, S., Jan, R. A., & Alsaedi, S. L. (2023) · Cureus · doi:10.7759/cureus.36957 · Cited by 72
Salamone, A., Zappettini, S., Grilli, M., Olivero, G., Agostinho, P. M., Tomé, Â. R., Chen, J., Pittaluga, A., Cunha, R. A., & Marchi, M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.12.014 · Cited by 44
Mahoney, J. J. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000245 · Cited by 48
Yoon, H. S., Kim, S., Park, H. K., & Kim, J. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.014 · Cited by 44
Fenu, S., & Chiara, G. D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02899.x · Cited by 45
Izawa, J.-I., Yamanashi, K., Asakura, T., Misu, Y., & Goshima, Y. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.031 · Cited by 44
Misra, K., & Pandey, S. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300900 · Cited by 44
Rubinstein, M. L., Luks, T. L., Dryden, W. Y., Rait, M. A., & Simpson, G. V. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr046 · Cited by 43
A Positive Affective Neuroendocrinology Approach to Reward and Behavioral Dysregulation
Welker, K. M., Gruber, J., & Mehta, P. H. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00093 · Cited by 47
Achat‐Mendes, C., Ali, S. F., & Itzhak, Y. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300675 · Cited by 43
Systems Level Neuroplasticity in Drug AddictionPreprint
Feltenstein, M. W., & See, R. E. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011916 · Cited by 46
Hardin, M. G., Perez-Edgar, K., Guyer, A. E., Pine, D. S., Fox, N. A., & Ernst, M. (2006) · Personality and Individual Differences · doi:10.1016/j.paid.2005.08.010 · Cited by 42
Segovia, K. N., Correa, M., Lennington, J. B., Conover, J. C., & Salamone, J. D. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08036.x · Cited by 40
Heroin Contaminated with Fentanyl Dramatically Enhances Brain Hypoxia and Induces Brain Hypothermia
Solis, E., Cameron-Burr, K. T., & Kiyatkin, E. A. (2017) · eNeuro · doi:10.1523/eneuro.0323-17.2017 · Cited by 45
Tirado-Muñoz, J., López-Rodríguez, A. B., Fonseca, F., Farré, M., Torrens, M., & Viveros, M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100841 · Cited by 45
Effect of Chronic Ethanol on Enkephalin in the Hypothalamus and Extra‐Hypothalamic Areas
Chang, G., Barson, J. R., Karatayev, O., Chang, S. Y. A., Chen, Y., & LEIBOWITZ, S. F. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01148.x · Cited by 44
Monoaminergic Psychomotor Stimulants: Discriminative Stimulus Effects and Dopamine Efflux
Desai, R. I., Paronis, C. A., Martin, J., Desai, R., & Bergman, J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165746 · Cited by 41
Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction
Cadoni, C. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00013 · Cited by 42
Murray, S. M., Tulloch, A. J., Criscitelli, K., & Avena, N. M. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.04.004 · Cited by 47
Devroye, C., Cathala, A., Piazza, P. V., & Spampinato, U. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.014 · Cited by 42
Müller, C. P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112672 · Cited by 45
Müller, C. P., Silva, M. A. D. S., & Huston, J. P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.002 · Cited by 41
Aujla, H., & Beninger, R. J. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00136-0 · Cited by 41
Forster, G. L., Anderson, E. M., Scholl, J. L., Lukkes, J. L., & Watt, M. J. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.08.001 · Cited by 40
Martin, B. J., Naughton, B. J., Rajamani, K. T., Yoon, D. J., Han, D. D., DeVries, A. C., & Gu, H. H. (2010) · Synapse · doi:10.1002/syn.20865 · Cited by 40
Brain reward region responsivity of adolescents with and without parental substance use disorders.
Stice, E. M., & Yokum, S. (2013) · Psychology of Addictive Behaviors · doi:10.1037/a0034460 · Cited by 41
Ventral Striatum Encodes Past and Predicted Value Independent of Motor Contingencies
Goldstein, B. L., Barnett, B. R., Vásquez, G. V. M., Tobia, S. C., Kashtelyan, V., Burton, A. C., Bryden, D. W., & Roesch, M. R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5349-11.2012 · Cited by 39
Sleep and metabolism: Role of hypothalamic neuronal circuitry
Rolls, A., Borg, J. S., & de Lecea, L. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.08.002 · Cited by 39
Stievenard, A., Méquinion, M., Andrews, Z. B., Destée, A., Chartier-Harlin, M.-C., Viltart, O., & Vanbesien-Mailliot, C. C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.021 · Cited by 39
Meta-Analysis of Structural and Functional Brain Abnormalities in Cocaine Addiction
Dang, J., Tao, Q., Niu, X., Zhang, M., Gao, X., Yang, Z., Yu, M., Wang, W., Han, S., Cheng, J., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.927075 · Cited by 39
Feier, G., Valvassori, S. S., Lopes-Borges, J., Varela, R. B., Bavaresco, D. V., Scaini, G., Morais, M. O. D. S., Andersen, M. L., STRECK, E. L., & Quevedo, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.039 · Cited by 39
Olière, S., Joliette-Riopel, A., Potvin, S., & Jutras‐Aswad, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00109 · Cited by 41
Carmichael, K., Sullivan, B. T., Lopez, E., Sun, L., & Cai, H. (2021) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.07 · Cited by 48
Howard, E. C., Schier, C. J., Wetzel, J., & Gonzales, R. A. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00965.x · Cited by 39
Pluzarev, O., & Pandey, S. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20216 · Cited by 39
Psychostimulant treatment of combat-related posttraumatic stress disorder
Houlihan, D. J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110385600 · Cited by 42
Misra, K., & Pandey, S. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.41 · Cited by 39
Midbrain-Driven Emotion and Reward Processing in Alcoholism
Müller-Oehring, E. M., Jung, Y.-C., Sullivan, E. V., Hawkes, W. C., Pfefferbaum, A., & Schulte, T. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.102 · Cited by 38
Stimulant and hallucinogenic novel psychoactive substances; an update
Schifano, F., Vento, A. E., Scherbaum, N., & Guirguis, A. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2279192 · Cited by 39
Ibrahim, K. M., Massaly, N., Yoon, H. J., Sandoval, R., Widman, A. J., Heuermann, R. J., Williams, S. B., Post, W., Pathiranage, S., Lintz, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44836-9 · Cited by 41
A role for Sv2c in basal ganglia functions
Dardou, D., Monlezun, S., Foerch, P., Courade, J., Cuvelier, L., Ryck, M. D., & Schiffmann, S. N. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.041 · Cited by 38
Neuroscience of opiates for addiction medicine
Zhou, Y., & Leri, F. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.09.001 · Cited by 37
Altered gating of Kv1.4 in the nucleus accumbens suppresses motivation for reward
O’Donovan, B., Adeluyi, A., Anderson, E. L., Cole, R. D., Turner, J. R., & Ortinski, P. I. (2019) · eLife · doi:10.7554/elife.47870 · Cited by 37
Seif, T., Makriyannis, A., Kunos, G., Bonci, A., & Hopf, F. W. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.055 · Cited by 37
Sparks, L. M., Sciascia, J. M., Ayorech, Z., & Chaudhri, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3292-5 · Cited by 37
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation
Seger, D. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.516263 · Cited by 37
Massive weight loss following deep brain stimulation of the nucleus accumbens in a depressed woman
Tronnier, V. M., Rasche, D., Thorns, V., Alvarez‐Fischer, D., Münte, T. F., & Zurowski, B. (2018) · Neurocase · doi:10.1080/13554794.2018.1431678 · Cited by 39
Onaolapo, O. J., & Onaolapo, A. Y. (2018) · World Journal of Psychiatry · doi:10.5498/wjp.v8.i2.64 · Cited by 39
Spina, L., Longoni, R., Vinci, S., Ibba, F., Peana, A. T., Muggironi, G., Spiga, S., & Acquas, E. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01129.x · Cited by 37
Quintanilla, M. E., Morales, P., Ezquer, F. E., Ezquer, M., Herrera‐Marschitz, M., & Israel, Y. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13842 · Cited by 37
Swanson, C. J., & Schoepp, D. D. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.019 · Cited by 37
Barson, J. R., Morganstern, I., & LEIBOWITZ, S. F. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_8 · Cited by 36
Bolger, G. B. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_4 · Cited by 37
Dynamic dichotomy of accumbal population activity underlies cocaine sensitization
van Zessen, R., Li, Y., Marion‐Poll, L., Hulo, N., Flakowski, J., & Lüscher, C. (2021) · eLife · doi:10.7554/elife.66048 · Cited by 36
Merrer, J. L., Gavello-Baudy, S., Galey, D., & Cazala, P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.014 · Cited by 37
Learning the morphine conditioned cue preference: Cue configuration determines effects of lesions
White, N. M., Chai, S.-C., & Hamdani, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.002 · Cited by 36
Cathala, A., Devroye, C., Maître, M., Piazza, P. V., Abrous, D. N., Revest, J., & Spampinato, U. (2014) · Addiction Biology · doi:10.1111/adb.12137 · Cited by 35
Metadata
- Authors
- Di Chiara, G.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 137
- Issue
- 1-2
- Pages
- 75-114
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W1980890656
- Cited by
- 996
- References
- 300
- Citations by year
- 2026: 17 · 2025: 28 · 2024: 30 · 2023: 24 · 2022: 33 · 2021: 30 · 2020: 30 · 2019: 40 · 2018: 40 · 2017: 39 · 2016: 45 · 2015: 56 · 2014: 49 · 2013: 54 · 2012: 54
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Brain Research (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nucleus accumbens shell, nucleus accumbens core, dopamine, drug addiction, incentive sensitization, self-administration, reinstatement, extinction, habituation
- MeSH terms
- Animals, Appetitive Behavior, Brain Mapping, Conditioning, Classical, Dopamine, Humans, Motivation, Neural Pathways, Synaptic Transmission, Nucleus Accumbens, Behavior, Addictive, Prefrontal Cortex, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
